J. M. Guernon, Y.-J. Wu / Tetrahedron Letters 52 (2011) 3633–3635
3635
pyridine-3-carbothioamide gave a somewhat lower yield (Table 1,
References and notes
entry 3). In addition to pyridine thioamides, reactions of 3 with
pyrazine, isoxazole, thiazole, and imidazole thioamides also pro-
ceeded smoothly to afford heteroaryl substituted bicyclic thiazoles
in good yields (Table 1, entries 4–7). When phenyl and substituted
phenyl thioamides were used in these Hantzsch reactions, the
yields were comparable to those from heteroaryl thioamides.
Among several simple alkyl thioamides evaluated, tert-butylthioa-
mide gave the highest yield (51%, Table 1, entry 13), and ethyl,
cyclopropyl, and benzyl thioamides afforded modest yields (ca.
30%, Table 1, entries 14–16). Hantzsch-type cyclizations also pro-
ceeded efficiently for thiourea substrates, with the highest yield
obtained from 1-(pyridin-4-yl)thiourea (Table 1, entry 17). A sali-
ent feature of this chemistry is that ester, sulfone, and N-BOC func-
tional groups are well tolerated (Table 1, entries 12, 21–23). While
the N-BOC pyrrolidine derivative (Table 1, entry 23) gave only a
modest yield, this result is comparable to the other alkyl deriva-
tives. However, only a trace amount of the desired product was ob-
served in the reaction with 2-cyanoethanethioamide (Table 1,
entry 24).
1. For a recent review on thiazole synthesis, see: Wu, Y.-J.; Yang, B. V. In Progress
in Heterocyclic Chemistry; Gribble, G. W., Joule, J. A., Eds.; Elsevier: New York,
2010. Vol. 22 pp. 259-348.
2. Doggrell, S. A. Expert Opin. Invest. Drugs 2005, 14, 89.
3. Lin, T. I.; Lenz, O.; Fanning, G.; Verbinnen, T.; Delouvroy, F.; Scholliers, A.;
Vermeiren, K.; Rosenquist, A.; Edlund, M.; Samuelson, B.; Vrang, L.; de Kock, H.;
Wigerinck, P.; Raboisson, P.; Simmen, K. Antimicrob. Agents Chemother. 2009,
53, 1377.
4. Dang, Q.; Kasibhatla, S. R.; Jiang, T.; Fen, K.; Liu, Y.; Taplin, F.; Schulz, W.;
Cashion, D. K.; Reddy, K. R.; van Poelje, P. D.; Fujitaki, J. M.; Potter, S. C.; Erion,
M. D. J. Med. Chem. 2008, 51, 4331.
5. Maillard, J.; Delaunay, P.; Langlois, M.; Portevin, B.; Legeai, J.; Manuel, C. Eur. J.
Med. Chem. 1984, 19(5), 451.
6. Denonne, F.; Celanire, S.; Provins, L.; Defays, S. PCT Int. Appl.
WO2008012010A1.
7. McIntyre, N. A.; McInnes, C.; Griffiths, G.; Barnett, A. L.; Kontopidis, G.; Slaqin,
A. M. Z.; Jackson, W.; Thomas, M.; Zheleva, D. I.; Wang, S.; Blake, D. G.;
Westwood, N. J.; Fischer, P. M. J. Med. Chem. 2010, 53, 2136.
8. Zhang, N.; Ayral-Kaloustian, S.; Mansour, T.S.; Nguyen, T.H.; Niu, C.; Rosfjord,
E.C.; Suayan, R.; Tsou, H.-R. PCT Int. Appl. WO2009120826A1.
9. Perry, B.; Alexander, R.; Bennett, G.; Buckley, G.; Ceska, T.; Crabbe, T.; Dale, V.;
Gowers, L.; Horsley, H.; James, L.; Jendins, K.; Crepy, K.; Kulisa, C.; Lightfoot, H.;
Lock, C.; Mack, S.; Morgan, T.; Nicolas, A.-L.; Pitt, W.; Sabin, V.; Wright, S. Bioorg.
Med. Chem. Lett. 2008, 18, 4700.
With the Hantzsch thiazole synthesis well established, we ex-
tended this methodology to the synthesis of bicyclic aminooxaz-
oles. Exposure of bromodiketone 3 to methyl, benzyl, and phenyl
ureas furnished the expected 2-aminooxazoles in good yields (Ta-
ble 2, entries 1–3). In the cases of 2-pyridyl urea and 2-chloroeeth-
ylurea, only a small amount of the desired 2-aminooxazole was
formed.
Finally, we utilized bromodiketone 3 for the synthesis of some
unique tricyclic imidazoles 8 (Table 3). Treatment of 3-bromocy-
clohexane-1,2-dione 3 with 2-aminopyridine and 2-aminothiazole
in refluxing ethanol resulted in the formation of their respective
tricyclic imidazole compounds in good yields (Table 3), although
the 2-aminobenzothiazole gave only a trace amount of the desired
product.
In summary, we have developed a convenient synthesis of pure,
air-stable 3-bromocyclohexane-1,2-dione 3. This bromide was
shown to be a versatile reagent for the Hantzsch thiazole synthesis
and the synthesis of other closely related heterocycles. The meth-
odology described has been successfully applied to the synthesis of
biologically active bicyclic thiazoles, and these compounds will be
reported in due course. With the wide variety of commercially
available thioamides, thioureas, amides, 2-aminothiazoles, and 2-
aminopyridines, we anticipate widespread application of this pro-
cedure to the synthesis of various bicyclic thiazoles and oxazoles,
as well as tricyclic imidazoles.
10. Modified procedure for the preparation of 3-bromocyclohexane-1,2-dione 3. To a
solution of 1,2-cyclohexanedione (5.1 g, 45.5 mmol) in diethyl ether (46 mL) at
0 °C was added Br2 (2.34 mL, 7.27 g, 45.5 mmol) dropwise over 10 min. When
the addition was complete, the reaction was allowed to come to room
temperature and stir for 15 min., at which time the reaction mixture was
concentrated in vacuo. The resulting dark oil was taken up in 2.5% MeOH/CHCl3
and run through a pad of silica gel, eluting with the same solvent mixture. The
solvent was then removed in vacuo and the resulting yellow solid was
triturated with minimal cold diethyl ether (approx. 15 mL). Filtration gave 3-
bromocyclohexane-1,2-dione as a white crystalline solid (4.1 g, 47%). 1H NMR
(500 MHz, CDCl3) d 6.43 (s, 1H), 2.90 (t, J = 6.0 Hz, 2H), 2.62–2.54 (m, 2H), 2.09
(dt, J = 13.0, 6.3 Hz, 2H). 13C NMR (126 MHz, CDCl3) d 191.7, 146.0, 119.4, 35.5,
34.5, 22.9. The carbon data as well as an hmqc experiment which showed no
cross peak of a carbon with the 6.43 ppm proton indicate that in solution, the
dione 3 exists exclusively in the enol form.
O
O
OH
Br
O
Br
11. Typical procedure for coupling of 3-bromocyclohexane-1,2-dione 3 in Hantzsch
and related reactions. A mixture of 3-bromocyclohexane-1,2-dione 3 (50 mg,
0.26 mmol) and pyridine-4-carbothioamide (24.1 mg, 0.17 mmol) in EtOH
(0.69 mL) was heated to reflux and stirred for 15 h. The reaction mixture was
diluted with DMSO (0.5 mL) to completely dissolve all solids and the resulting
mixture was purified by directly injecting the reaction mixture into
a
preparatory HPLC (C18, water/acetonitrile/ammonium acetate buffer) to give
2-(pyridin-4-yl)-6,7-dihydrobenzo[d]thiazol-4(5H)-one (30.4 mg, 0.13 mmol,
76%) (Table 1, entry 1). LC-MS (M+H)+ = 231.1. 1H NMR (500 MHz, CDCl3) d
8.80–8.69 (m, 2H), 7.95–7.80 (m, 2H), 3.22 (t, J = 6.1 Hz, 2H), 2.76 (dd, J = 7.2,
6.0 Hz, 2H), 2.38–2.29 (m, 2H). 13C NMR (126 MHz, CDCl3) d 190.9, 163.3,
152.7, 150.9, 150.5, 139.7, 120.8, 38.3, 24.6, 23.9.
Acknowledgments
We would like to thank Dr. Lorin A. Thompson and Dr. John E.
Macor for their encouragement.